What is Albemarle's market cap?

Albemarle (ALB) has a market capitalization of $15.3B and trades on NYSE.

What is Albemarle's revenue and profitability?

Albemarle generated $5.5B in trailing twelve-month revenue with a net loss of $232.9M, representing a net margin of -4.2%. Gross margin stands at 18.4%, with free cash flow of $1.1B. These figures are based on the Q1 2026 filing.

Who are Albemarle's competitors?

Albemarle's key competitors include Sociedad Quimica y Minera de Chile, 5E Advanced Materials, Inc. Common Stock, Atlas Lithium Corporation Common Stock, and others. These companies compete in similar markets and product categories.

What subsidiaries does Albemarle have?

Albemarle's subsidiaries include Ketjen.

Where is Albemarle headquartered?

Albemarle is headquartered in United States of America and employs approximately 9,000 people. It has been publicly traded since 1994.

Albemarle

ALB

Albemarle Corporation is a global leader in the development and manufacturing of highly engineered specialty chemicals.

Market cap

$15.26B+92.9%

Revenue$5.5B+7.9%

Net income-$232.9M+80.9%

Free cash flow$1.1B+208%

EPS (diluted)-$3.42+70.0%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$1.4BBeat by $88.5M EPS$2.95Beat by $1.71

Read the full report

Next report

Aug 5, 2026 (In 3 weeks)

Revenue estimate$1.6B

EPS estimate$3.03

Financials

Q1 2026

Income statement

See full

Revenue$1.4B+32.7%

Gross profit$501.0M+221%

Operating income$233.5M+1,082%

Net income$319.1M+672%

EPS (diluted)$2.34—

Balance sheet

See full

Cash & equivalents$1.1B-28.2%

Total debt$2.1B-44.3%

Total equity$9.9B-1.8%

Total assets$15.1B-10.9%

Cash flow

See full

Operating cash flow$346.2M-36.7%

CapEx$98.7M-46.0%

Free cash flow$247.6M-32.1%

Valuation & ratios

Valuation

See full

Market cap$15.26B+92.9%

Enterprise value$16.28B+63.4%

P/S2.8×+1.2×

Profitability

See full

Gross margin18.4%+14.9pp

Operating margin-2.8%-1.3pp

Net margin-4.2%-1.9pp

Returns & leverage

See full

Return on equity-2.3%-1.0pp

Debt / equity0.2×-0.2×

Current ratio2.1×0.0×

Segments

By segment

See full

Energy Storage$891.2M+69.9%

Specialties$358.4M+11.7%

Competitors

By market cap

Albemarle$15.3B+92.9%

Westlake$9.7B-6.6%

Lithium Americas$1.3B+116%

American Battery Technology Company$356.0M+110%

Future Fuel$205.3M+12.4%

Atlas Lithium Corporation$99.7M+44.4%

5E Advanced Materials, Inc.$54.0M-26.7%

Stardust Power, Inc.$17.8M+3.1%

By revenue growth

American Battery Technology Company+918%

Albemarle+7.9%

Westlake-8.6%

Future Fuel-45.6%

Atlas Lithium Corporation-71.7%

By net margin

Albemarle-4.24%+19.6pp

Westlake-14.91%-18.1pp

Future Fuel-47.51%-44.1pp

American Battery Technology Company-390.48%+3,361pp

Atlas Lithium Corporation-23,042.05%-15,398pp

Profile

Albemarle Corporation is a global leader in the development and manufacturing of highly engineered specialty chemicals. The company focuses on transforming essential resources into critical ingredients for high-growth end markets including electric vehicle mobility, energy storage, and pharmaceutical health.

Competitive position

A dominant global player in the lithium market with a vertically integrated supply chain and significant intellectual property in bromine and catalyst chemistry.

GeographiesNorth America, Asia-Pacific, Europe, South America

Customer segmentsAutomotive manufacturers, Energy utilities, Consumer electronics producers, Pharmaceutical labs

Business modelResource extraction and processing, B2B manufacturing, Joint venture operations

SuppliersBrine resources, Spodumene ore, Raw chemical feedstocks, Energy for processing

CustomersElectric vehicle manufacturers, Battery cell producers, Refining companies, Medical device manufacturers

CountryUnited States of America

Listed1994

Employees9.0K

CEOJerry Kent Jr.

SectorBasic Materials

IndustryChemicals - Specialty

Websitealbemarle.com

FilingsSEC EDGAR

Ask your AI about Albemarle.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Albemarle's market cap?: Albemarle (ALB) has a market capitalization of $15.3B and trades on NYSE.
What is Albemarle's revenue and profitability?: Albemarle generated $5.5B in trailing twelve-month revenue with a net loss of $232.9M, representing a net margin of -4.2%. Gross margin stands at 18.4%, with free cash flow of $1.1B. These figures are based on the Q1 2026 filing.
Who are Albemarle's competitors?: Albemarle's key competitors include Sociedad Quimica y Minera de Chile, 5E Advanced Materials, Inc. Common Stock, Atlas Lithium Corporation Common Stock, and others. These companies compete in similar markets and product categories.
What subsidiaries does Albemarle have?: Albemarle's subsidiaries include Ketjen.
Where is Albemarle headquartered?: Albemarle is headquartered in United States of America and employs approximately 9,000 people. It has been publicly traded since 1994.